MedPath

efficacy of skin pigment suspension in treatment of white burn scars

Phase 2
Conditions
post-burn leukoderma.
Leukoderma, not elsewhere classified
Registration Number
IRCT2016013026269N1
Lead Sponsor
Vice Chancellor for research of Isfahan University of Medical Sciences.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
42
Inclusion Criteria

Age =18 years; Non-pregnant and non-breast feeding women; without history of chronic diseases, skin cancer, drug sensitivity/sever allergic reactions, immun deficient, organ transplant or steroid treatment; The absence of coagulopathy or anticoagulation therapy; No evidence of hypertrophic burn scar; The total area treated is >40 cm2. Exclusion criteria: Previous treatment of skin lesions; Active systemic infection.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Repigmentation scales. Timepoint: one, three and six months after the end of treatment. Method of measurement: by dermatology Colleagues blinded to the randomization.
Secondary Outcome Measures
NameTimeMethod
Edema, Erythema, Infection and Dyspigmentation. Timepoint: One week, ane month, three months and six months after treatment. Method of measurement: Eye Clinical Evaluation.
© Copyright 2025. All Rights Reserved by MedPath